In recently published studies, researchers at Lund University and Skåne University Hospital in Sweden have produced new prediction models for improved personalized treatment of lymph nodes in breast cancer patients. The ...
Sep 20, 2019
0
41
Breast cancer is a common illness around the world. It is the most common invasive of cancers in women and affects around one in eight and represents about a quarter of all invasive cancers.
Sep 11, 2019
0
3
Cancer treatments can work in lots of different ways, aiming to kill tumor cells or keep them under control. Ideally they cause tumors to shrink, but drugs can also be considered successful if they stop tumors growing.
Aug 30, 2019
0
1
Scientists have used artificial intelligence to recognise patterns in breast cancer—and uncovered five new types of the disease each matched to different personalised treatments.
Aug 2, 2019
0
69
"Cancer has a way of evolving and adapting," says Dr. Mariam Jamal-Hanjani, a cancer doctor and researcher at the Cancer Research UK Lung Cancer Centre of Excellence. "When tumours are under selection pressures, for example ...
May 29, 2019
0
59
Walter and Eliza Hall Institute researchers have developed a new imaging technique to visualise key steps in the evolution of cancer cells within tumours, potentially revealing how breast cancers evade treatment.
Mar 28, 2019
0
6
Anyone who has ever studied the molecular basis of breast cancer will probably have heard of BRCA1, a protein that protects the cells of breast tissue against cancer. Surprisingly, this protein can also have the opposite ...
Mar 20, 2019
0
33
Scientists have identified genetic changes that may predict the likelihood of breast cancer relapse in women taking a common type of hormone therapy.
Jan 22, 2019
0
6
A class of drugs used to treat certain breast cancers could help to tackle lung cancers that have become resistant to targeted therapies, suggests a new study in mice from the Francis Crick Institute and the Institute of ...
Dec 26, 2018
0
405
The well-known drug tamoxifen could exploit a weakness in the physical 'scaffolds' around tumours, according to research led by Imperial.
Dec 11, 2018
0
7
